title: Asp Viper (Vipera aspis) envenomation: experience of the Marseille Poison Centre from 1996 to 2008.
abstract: A retrospective case review study of viper envenomations collected by the Marseille's Poison Centre between 1996 and 2008 was performed.
  
  
  
  174 cases were studied (52 grade 1 = G1, 90 G2 and 32 G3). G1 patients received symptomatic treatments (average hospital stay 0.96 day). One hundred and six (106) of the G2/G3 patients were treated with the antivenom Viperfav* (2.1+/-0.9 days in hospital), while 15 of them received symptomatic treatments only (plus one immediate death) (8.1+/-4 days in hospital, 2 of them died). The hospital stay was significantly reduced in the antivenom treated group (p < 0.001), and none of the 106 antivenom treated patients had immediate (anaphylaxis) or delayed (serum sickness) allergic reactions.
  
  
  
  Viperfav* antivenom was safe and effective for treating asp viper venom-induced toxicity.
authors: Centre Antipoison, hôpital Salvator, 249 boulevard Sainte Marguerite, 13009 Marseille, France. luc.deharo@ap-hm.fr
authors: Luc
authors: L
authors: de Haro
authors: Mathieu
authors: M
authors: Glaizal
authors: Lucia
authors: L
authors: Tichadou
authors: Ingrid
authors: I
authors: Blanc-Brisset
authors: Maryvonne
authors: M
authors: Hayek-Lanthois
mesh_terms: D000818:Animals; D000997:Antivenins / Q000494:pharmacology; D006801:Humans; D011042:Poisons; D012189:Retrospective Studies; D012909:Snake Bites / Q000628:therapy; D014757:Viper Venoms; D017819:Viperidae
chemical_list: D000997:Antivenins; D011042:Poisons; D014757:Viper Venoms